First, the conditional deletion of all MHC-I molecules from cDC1, using Xcr1-Cre crossed with a floxed allele of β2 microglobulin, confirmed the expected peptide: MHC interactions with CD8 T cells in tumor rejection. This evidence concerns the gene XCR1 and neoplasm.